Cargando…
Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
Infections with herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are a global health burden. Besides painful oral or genital lesions in otherwise healthy subjects, both viruses can cause devastating morbidity and mortality in immune-compromised and immune-immature individuals. The latter are p...
Autores principales: | Silke Heilingloh, Christiane, Lull, Christopher, Kleiser, Elissa, Alt, Mira, Schipper, Leonie, Witzke, Oliver, Trilling, Mirko, Eis-Hübinger, Anna-Maria, Dittmer, Ulf, Krawczyk, Adalbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563860/ https://www.ncbi.nlm.nih.gov/pubmed/32867086 http://dx.doi.org/10.3390/vaccines8030478 |
Ejemplares similares
-
Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
por: Alt, Mira, et al.
Publicado: (2018) -
Role of L-Particles during Herpes Simplex Virus Infection
por: Heilingloh, Christiane S., et al.
Publicado: (2017) -
Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses
por: van de Sand, Lukas, et al.
Publicado: (2021) -
A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease
por: Bauer, Dirk, et al.
Publicado: (2017) -
Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study
por: Alt, Mira, et al.
Publicado: (2023)